MetLife MET
$98.27 −$1.48 (-1.48%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $98.27 0.00%
Open$98.34
Prev close$99.75
Day range$97.78 – $99.51
Volume3.33M
Market cap$62.02B
P/E (TTM)12.8
Dividend yield2.36%
MET Stock News
Headlines matching MetLife or the MET ticker, most recent first.
- Hailanxin (300065.SZ): No overseas orders for underwater data centers have met disclosure standards.
- Top U.S. Stock Performers This Week | Roivant Sciences surged more than 17% this week as Phase II data for mosliciguat, developed by its subsidiary, met endpoints in treating PH-ILD; Cloudflare rose nearly 12%, indirectly benefiting as an edge computing p Positive
- US August PPI month-on-month growth met expectations, while year-on-year growth slightly exceeded forecasts. Positive
- Court Closes Light S.A. Judicial Reorganization After Plan Obligations Met
- The new iPhone launch met expectations and drove an increase in ASP, but the outlook for the iPhone remains uncertain.
- Inovance Technology (300124): 1H2026 performance met expectations; general automation business achieved steady growth. Positive
- Wang Jun, Deputy Commissioner of the General Administration of Customs, met with Habib Tucci, Secretary General of the International Road Transport Union (IRU), at the Administration.
- Raymond James Maintains MetLife(MET.US) With Hold Rating
- Kelun-Biotech (06990.HK): H1 2026 product sales met expectations; domestic volume growth of sac-TMT and overseas development continue to advance. Positive
- Hutchmed (00013.HK) announced the submission of a New Drug Application (NDA) in the United States for the combination of ORPATHYS and TAGRISSO for the treatment of MET-driven EGFR-mutated lung cancer.
- Piper Sandler Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $110
- Piper Sandler Upgrades MetLife(MET.US) to Buy Rating, Raises Target Price to $110 Positive
- BYD (002594) 2026 Interim Report Commentary: Q2 results met expectations, and the trend of year-on-year and quarter-on-quarter improvement in per-vehicle profitability has been established.
- Kuaishou-W (01024.HK) Q2 2026 Earnings Review: Second-quarter results met expectations; short-term headwinds persist, but the valuation is already attractive.
- Yanhua Shares (000792): Price and volume dynamics fully realized; dividend eligibility likely to be met within the year.
No comments yet — be the first to weigh in on MET.
Sign in to join the discussion.